vs
AdvanSix Inc.（ASIX）与科迪华（CTVA）财务数据对比。点击上方公司名可切换其他公司
科迪华的季度营收约是AdvanSix Inc.的10.9倍（$3.9B vs $359.9M）。AdvanSix Inc.净利率更高（-0.8% vs -14.1%，领先13.3%）。AdvanSix Inc.同比增速更快（9.4% vs -1.7%）。科迪华自由现金流更多（$4.2B vs $36.1M）。过去两年AdvanSix Inc.的营收复合增速更高（3.4% vs -6.7%）
AdvanSix Inc.是一家美国化工企业，主营尼龙6以及己内酰胺、硫酸铵肥料等相关化工产品。该公司原为霍尼韦尔旗下树脂与化工事业部，于2016年分拆独立，2019年预估营收达14亿美元，其企业历史可追溯至1884年在宾夕法尼亚州法兰克福成立的H. W. Jayne公司。
科迪华是一家美国农业科技企业，主营种子与作物保护产品，涵盖除草剂、杀虫剂、杀菌剂及生物制剂，业务覆盖全球110个国家，总部位于印第安纳州印第安纳波利斯，旗下大部分种子产品以先锋良种国际品牌销售。
ASIX vs CTVA — 直观对比
营收规模更大
CTVA
是对方的10.9倍
$359.9M
营收增速更快
ASIX
高出11.1%
-1.7%
净利率更高
ASIX
高出13.3%
-14.1%
自由现金流更多
CTVA
多$4.1B
$36.1M
两年增速更快
ASIX
近两年复合增速
-6.7%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $359.9M | $3.9B |
| 净利润 | $-2.8M | $-552.0M |
| 毛利率 | 7.6% | 42.4% |
| 营业利润率 | -0.7% | -13.6% |
| 净利率 | -0.8% | -14.1% |
| 营收同比 | 9.4% | -1.7% |
| 净利润同比 | -892.9% | -1246.3% |
| 每股收益（稀释后） | $-0.11 | $-0.80 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASIXCTVA
| Q4 25 | $359.9M | $3.9B | ||
| Q3 25 | $374.5M | $2.6B | ||
| Q2 25 | $410.0M | $6.5B | ||
| Q1 25 | $377.8M | $4.4B | ||
| Q4 24 | $329.1M | $4.0B | ||
| Q3 24 | $398.2M | $2.3B | ||
| Q2 24 | $453.5M | $6.1B | ||
| Q1 24 | $336.8M | $4.5B |
净利润ASIXCTVA
| Q4 25 | $-2.8M | $-552.0M | ||
| Q3 25 | $-2.6M | $-320.0M | ||
| Q2 25 | $31.4M | $1.3B | ||
| Q1 25 | $23.3M | $652.0M | ||
| Q4 24 | $352.0K | $-41.0M | ||
| Q3 24 | $22.3M | $-524.0M | ||
| Q2 24 | $38.9M | $1.1B | ||
| Q1 24 | $-17.4M | $419.0M |
毛利率ASIXCTVA
| Q4 25 | 7.6% | 42.4% | ||
| Q3 25 | 6.8% | 37.2% | ||
| Q2 25 | 14.3% | 54.6% | ||
| Q1 25 | 14.2% | 47.0% | ||
| Q4 24 | 3.4% | 37.3% | ||
| Q3 24 | 14.4% | 32.7% | ||
| Q2 24 | 17.9% | 52.3% | ||
| Q1 24 | 0.9% | 43.2% |
营业利润率ASIXCTVA
| Q4 25 | -0.7% | -13.6% | ||
| Q3 25 | -0.9% | -14.1% | ||
| Q2 25 | 7.7% | 27.9% | ||
| Q1 25 | 7.7% | 17.7% | ||
| Q4 24 | -3.9% | 2.2% | ||
| Q3 24 | 7.5% | -27.2% | ||
| Q2 24 | 11.5% | 21.9% | ||
| Q1 24 | -7.0% | 10.7% |
净利率ASIXCTVA
| Q4 25 | -0.8% | -14.1% | ||
| Q3 25 | -0.7% | -12.2% | ||
| Q2 25 | 7.7% | 20.4% | ||
| Q1 25 | 6.2% | 14.8% | ||
| Q4 24 | 0.1% | -1.0% | ||
| Q3 24 | 5.6% | -22.5% | ||
| Q2 24 | 8.6% | 17.2% | ||
| Q1 24 | -5.2% | 9.3% |
每股收益（稀释后）ASIXCTVA
| Q4 25 | $-0.11 | $-0.80 | ||
| Q3 25 | $-0.10 | $-0.47 | ||
| Q2 25 | $1.15 | $1.92 | ||
| Q1 25 | $0.86 | $0.95 | ||
| Q4 24 | $0.02 | $-0.05 | ||
| Q3 24 | $0.82 | $-0.76 | ||
| Q2 24 | $1.43 | $1.51 | ||
| Q1 24 | $-0.65 | $0.60 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $19.8M | $4.5B |
| 总债务越低越好 | — | $1.7B |
| 股东权益账面价值 | $815.2M | $24.1B |
| 总资产 | $1.7B | $42.8B |
| 负债/权益比越低杠杆越低 | — | 0.07× |
8季度趋势，按日历期对齐
现金及短期投资ASIXCTVA
| Q4 25 | $19.8M | $4.5B | ||
| Q3 25 | $23.7M | $2.6B | ||
| Q2 25 | $18.4M | $2.1B | ||
| Q1 25 | $8.3M | $2.0B | ||
| Q4 24 | $19.6M | $3.2B | ||
| Q3 24 | $17.3M | $2.5B | ||
| Q2 24 | $12.1M | $2.0B | ||
| Q1 24 | $20.6M | $1.7B |
总债务ASIXCTVA
| Q4 25 | — | $1.7B | ||
| Q3 25 | — | $1.7B | ||
| Q2 25 | — | $1.7B | ||
| Q1 25 | — | $1.8B | ||
| Q4 24 | — | $2.0B | ||
| Q3 24 | — | $2.0B | ||
| Q2 24 | — | $2.5B | ||
| Q1 24 | — | $2.5B |
股东权益ASIXCTVA
| Q4 25 | $815.2M | $24.1B | ||
| Q3 25 | $818.2M | $25.2B | ||
| Q2 25 | $823.7M | $25.9B | ||
| Q1 25 | $794.4M | $24.3B | ||
| Q4 24 | $774.6M | $23.8B | ||
| Q3 24 | $766.4M | $24.7B | ||
| Q2 24 | $746.6M | $25.2B | ||
| Q1 24 | $713.2M | $24.8B |
总资产ASIXCTVA
| Q4 25 | $1.7B | $42.8B | ||
| Q3 25 | $1.7B | $42.2B | ||
| Q2 25 | $1.6B | $41.8B | ||
| Q1 25 | $1.6B | $42.1B | ||
| Q4 24 | $1.6B | $40.8B | ||
| Q3 24 | $1.5B | $41.9B | ||
| Q2 24 | $1.5B | $41.5B | ||
| Q1 24 | $1.5B | $43.6B |
负债/权益比ASIXCTVA
| Q4 25 | — | 0.07× | ||
| Q3 25 | — | 0.07× | ||
| Q2 25 | — | 0.07× | ||
| Q1 25 | — | 0.07× | ||
| Q4 24 | — | 0.08× | ||
| Q3 24 | — | 0.08× | ||
| Q2 24 | — | 0.10× | ||
| Q1 24 | — | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $63.7M | $4.4B |
| 自由现金流经营现金流 - 资本支出 | $36.1M | $4.2B |
| 自由现金流率自由现金流/营收 | 10.0% | 106.2% |
| 资本支出强度资本支出/营收 | 7.7% | 5.7% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $6.4M | $2.8B |
8季度趋势，按日历期对齐
经营现金流ASIXCTVA
| Q4 25 | $63.7M | $4.4B | ||
| Q3 25 | $26.6M | $193.0M | ||
| Q2 25 | $21.1M | $947.0M | ||
| Q1 25 | $11.4M | $-2.1B | ||
| Q4 24 | $64.2M | $4.2B | ||
| Q3 24 | $57.3M | $130.0M | ||
| Q2 24 | $50.2M | $451.0M | ||
| Q1 24 | $-36.2M | $-2.6B |
自由现金流ASIXCTVA
| Q4 25 | $36.1M | $4.2B | ||
| Q3 25 | $66.0K | $36.0M | ||
| Q2 25 | $-7.2M | $829.0M | ||
| Q1 25 | $-22.6M | $-2.2B | ||
| Q4 24 | $29.8M | $4.0B | ||
| Q3 24 | $26.8M | $-24.0M | ||
| Q2 24 | $16.7M | $337.0M | ||
| Q1 24 | $-71.6M | $-2.8B |
自由现金流率ASIXCTVA
| Q4 25 | 10.0% | 106.2% | ||
| Q3 25 | 0.0% | 1.4% | ||
| Q2 25 | -1.7% | 12.8% | ||
| Q1 25 | -6.0% | -49.9% | ||
| Q4 24 | 9.1% | 100.4% | ||
| Q3 24 | 6.7% | -1.0% | ||
| Q2 24 | 3.7% | 5.5% | ||
| Q1 24 | -21.3% | -61.4% |
资本支出强度ASIXCTVA
| Q4 25 | 7.7% | 5.7% | ||
| Q3 25 | 7.1% | 6.0% | ||
| Q2 25 | 6.9% | 1.8% | ||
| Q1 25 | 9.0% | 2.1% | ||
| Q4 24 | 10.4% | 4.6% | ||
| Q3 24 | 7.7% | 6.6% | ||
| Q2 24 | 7.4% | 1.9% | ||
| Q1 24 | 10.5% | 3.3% |
现金转化率ASIXCTVA
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.67× | 0.72× | ||
| Q1 25 | 0.49× | -3.23× | ||
| Q4 24 | 182.29× | — | ||
| Q3 24 | 2.57× | — | ||
| Q2 24 | 1.29× | 0.43× | ||
| Q1 24 | — | -6.23× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASIX
| Plant Nutrients | $140.0M | 39% |
| Chemical Intermediates | $92.8M | 26% |
| Caprolactam | $64.4M | 18% |
| Nylon Resins | $62.8M | 17% |
CTVA
| Corn | $1.4B | 35% |
| Herbicides | $1.1B | 27% |
| Insecticides | $488.0M | 12% |
| Fungicides | $272.0M | 7% |
| Biologicals | $191.0M | 5% |
| Soybean | $164.0M | 4% |
| Other | $160.0M | 4% |
| Otheroilseeds | $94.0M | 2% |
